Results 131 to 140 of about 4,641 (209)

Control of sleeping sickness due to Trypanosoma brucei gambiense.

Bulletin of the World Health Organization, 1983
Sleeping sickness due to Trypanosoma brucei gambiense is endemic in 23 African countries and an estimated 45 million people are exposed to infection. The relatively low incidence of the disease (about 10 000 new cases each year) is mainly a result of 50 years of regular medical surveillance and treatment in combination with tsetse control where ...
openaire   +2 more sources

The effect of livestock density on Trypanosoma brucei gambiense and T. b. rhodesiense: A causal inference-based approach. [PDF]

PLoS Negl Trop Dis, 2022
Meisner J, Kato A, Lemerani MM, Mwamba Miaka E, Ismail Taban A, Wakefield J, Rowhani-Rahbar A, Pigott DM, Mayer JD, Rabinowitz PM.   +9 more
europepmc   +1 more source

Development of tools to improve the detection of Trypanosoma evansi in Australia [PDF]

, 2009
The aim of this study was to evaluate new methods to improve detection and investigation of the effects of chronic or subclinical infection with Trypanosoma evansi in various mammalian species.
Smuts, Celia
core  

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. [PDF]

Lancet Infect Dis, 2023
Betu Kumeso VK, Kalonji WM, Rembry S, Valverde Mordt O, Ngolo Tete D, Prêtre A, Delhomme S, Ilunga Wa Kyhi M, Camara M, Catusse J, Schneitter S, Nusbaumer M, Mwamba Miaka E, Mahenzi Mbembo H, Makaya Mayawula J, Layba Camara M, Akwaso Massa F, Kaninda Badibabi L, Kasongo Bonama A, Kavunga Lukula P, Mutanda Kalonji S, Mariero Philemon P, Mokilifi Nganyonyi R, Embana Mankiara H, Asuka Akongo Nguba A, Kobo Muanza V, Mulenge Nasandhel E, Fifi Nzeza Bambuwu A, Scherrer B, Strub-Wourgaft N, Tarral A.   +30 more
europepmc   +1 more source

A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro

, 2013
Recently, the World Health Organization approved the nifurtimox–eflornithine combination therapy for the treatment of human African trypanosomiasis, renewing interest in nitroheterocycle therapies for this and associated diseases.
Smith, Terry K, Westwood, Nicholas J, Rideau, Emeline, Stewart, Gavin, Zhou, Linna, Westwood, Nicholas James   +5 more
core   +1 more source

Trypanosoma brucei gambiense [PDF]

, 2020
openaire   +1 more source

Loop-mediated isothermal amplification (LAMP) method for rapid detection of Trypanosoma brucei rhodesiense

, 2008
Loop-mediated isothermal amplification (LAMP) of DNA is a novel technique that rapidly amplifies target DNA under isothermal conditions. In the present study, a LAMP test was designed from the serum resistance-associated (SRA) gene of Trypanosoma brucei ...
Ndung'u, J.M., Njiru, Z.K., Enyaru, J.C., Thompson, R.C.A., Mikosza, A., Armstrong, T.   +5 more
core  

Unusual MRI Findings in African Trypanosoma brucei gambiense Trypanosomiasis: Dentate Nuclei and Hypothalamic Lesions. [PDF]

Am J Trop Med Hyg, 2020
Boukobza M, Lariven S, Houzé S, Laissy JP.   +3 more
europepmc   +1 more source

A pilot study demonstrating the identification of Trypanosoma brucei gambiense and T. b. rhodesiense in vectors using a multiplexed high-resolution melt qPCR. [PDF]

PLoS Negl Trop Dis, 2020
Garrod G, Adams ER, Lingley JK, Saldanha I, Torr SJ, Cunningham LJ.   +5 more
europepmc   +1 more source

The detection and treatment of human African trypanosomiasis

Research and Reports in Tropical Medicine, 2012
Bernard Bouteille,1 Alain Buguet21Laboratory of Parasitology, Dupuytren University Hospital of Limoges, France; 2Polyclinic Marie-Louise Poto-Djembo, Pointe-Noire, CongoAbstract: Human African trypanosomiasis (HAT) is caused by the injection of ...
Bouteille B, Buguet A
doaj